Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02001402
Other study ID # 83573214
Secondary ID
Status Enrolling by invitation
Phase N/A
First received November 20, 2013
Last updated November 27, 2013
Start date August 2008
Est. completion date September 2016

Study information

Verified date November 2013
Source Peking University First Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

A follow-up intervention for the climacteric symptoms of nurses in Peking


Description:

As we all know,hormone replacement therapy (HRT) is the main therapy to climacteric symptoms.But HRT has also some disadvantages including breast cancer,cardiovascular disease and so on, especially long period of HRT. It makes us to find the non-hormone therapy. So we want to investigate the exercise on the effect of climacteric symptoms.Doing exercise is helpful for avoiding and treating many disease,including climacteric symptoms.In our previous research,we found that playing exercise can treat moderate climacteric symptoms.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 2
Est. completion date September 2016
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 55 Years
Eligibility Inclusion Criteria:

- they are nurse ,aged40-55, lived in peking ,who are among perimenopausal women.

Exclusion Criteria:

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Bai Wen-Pei

Outcome

Type Measure Description Time frame Safety issue
Primary the number of KMI KMI is the short of Kupperman index, which is a questionnaire that assesses the severity of women's climacteric symptoms. up to 2 years Yes
Secondary blood lipid blood lipid is an index to measure the effect of exercise. up to 2 years Yes
See also
  Status Clinical Trial Phase
Completed NCT01741974 - Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women Phase 3
Not yet recruiting NCT05522621 - A Muticenter Clinical Study of Chinese Herbal Compound TJAOA102 in Alleviating Menopausal Syndrome Early Phase 1
Completed NCT01046643 - Early Menopause Hormone Treatment and Cognition N/A
Active, not recruiting NCT00694733 - Regulation of Cortisol Metabolism and Fat Patterning N/A
Completed NCT05759936 - 4-week Seaweed Supplementation on Menopause Symptoms and Psychological Wellbeing N/A
Completed NCT05266079 - Comparison Study for Perimenopausal Syndrome With Chinese Herbal Medicine N/A
Completed NCT04520542 - The Effect of Acupressure Application on Menopausal Symptoms N/A
Completed NCT02749747 - Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric Phase 3
Completed NCT01849172 - Effect and Safety of Electroacupuncture for Symptoms of Menopausal Transition N/A
Enrolling by invitation NCT03948269 - The Effect of Internet- and Mobile-based Group Treatment in Menopausal Women N/A
Recruiting NCT04031456 - Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients Phase 2/Phase 3
Recruiting NCT02294500 - Cohort Study to Evaluate Ovarian Function N/A
Completed NCT02467673 - Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy Phase 2
Recruiting NCT05280028 - HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness
Completed NCT00289926 - Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms Phase 3
Recruiting NCT01698164 - Multi-centre Clinical Trial on Hormone Replacement Treatment in China Phase 4
Completed NCT05463081 - Clinical Trial of "Magic Gyno" Laser Device N/A
Completed NCT00933725 - Efficacy and Safety of Traditional Chinese Medicine Intervention for Women With Menopausal Syndrome Phase 3
Recruiting NCT04726254 - The JULI Registry--Hemp and Cannabis Observational Registry
Completed NCT01931748 - A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome Phase 3